BMED vs. GERM

Last updated Apr 2, 2026

Compare and contrast key facts about Future Health ETF (BMED) and Amplify Treatments, Testing and Advancements ETF (GERM).

BMED and GERM are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BMED is an actively managed fund by BlackRock. It was launched on Sep 29, 2020. GERM is a passively managed fund by Amplify that tracks the performance of the Prime Treatments, Testing and Advancements Index. It was launched on Jun 17, 2020.

Performance

BMED vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Future Health ETF (BMED) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

BMED vs. GERM - Yearly Performance Comparison

	2026 (YTD)	2025	2024
BMED Future Health ETF	-4.26%	21.79%	-2.83%
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%

Returns By Period

BMED

• 1D: 0.34%
• 1M: -5.51%
• YTD: -4.26%
• 6M: 5.68%
• 1Y: 22.21%
• 3Y*: 7.39%
• 5Y*: 0.40%
• 10Y*: —

GERM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 0.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BMED vs. GERM - Expense Ratio Comparison

BMED has a 0.85% expense ratio, which is higher than GERM's 0.68% expense ratio.

BMED

Future Health ETF

GERM

Amplify Treatments, Testing and Advancements ETF

Return for Risk

BMED vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMED

BMED Risk / Return Rank: 61
BMED Sharpe Ratio Rank: 66
BMED Sortino Ratio Rank: 66
BMED Omega Ratio Rank: 61
BMED Calmar Ratio Rank: 58
BMED Martin Ratio Rank: 53

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BMED vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Future Health ETF (BMED) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BMED	GERM	Difference
Sharpe ratio Return per unit of total volatility	1.23	—	—
Sortino ratio Return per unit of downside risk	1.75	—	—
Omega ratio Gain probability vs. loss probability	1.24	—	—
Calmar ratio Return relative to maximum drawdown	1.60	—	—
Martin ratio Return relative to average drawdown	5.45	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	BMED	GERM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.23	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.02	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.13	—	—

Dividends

BMED vs. GERM - Dividend Comparison

Neither BMED nor GERM has paid dividends to shareholders.

	TTM	2025	2024	2023
BMED Future Health ETF	0.00%	0.00%	0.00%	0.03%
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%	0.00%

Drawdowns

BMED vs. GERM - Drawdown Comparison

The maximum BMED drawdown since its inception was -36.44%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for BMED and GERM.

Drawdown Indicators

	BMED	GERM	Difference
Max Drawdown Largest peak-to-trough decline	-36.44%	0.00%	-36.44%
Max Drawdown (1Y) Largest decline over 1 year	-12.31%	0.00%	-12.31%
Max Drawdown (5Y) Largest decline over 5 years	-33.90%	—	—
Current Drawdown Current decline from peak	-10.30%	0.00%	-10.30%
Average Drawdown Average peak-to-trough decline	-19.30%	0.00%	-19.30%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.62%	0.00%	+3.62%

Volatility

BMED vs. GERM - Volatility Comparison

Future Health ETF (BMED) has a higher volatility of 5.98% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that BMED's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BMED	GERM	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.98%	0.00%	+5.98%
Volatility (6M) Calculated over the trailing 6-month period	10.87%	0.00%	+10.87%
Volatility (1Y) Calculated over the trailing 1-year period	18.24%	0.00%	+18.24%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.42%	0.00%	+17.42%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.81%	0.00%	+17.81%